C1QTNF9 and atherosclerosis: For the therapeutic prevention of vascular disease, CTRP3 may be a novel target for preventing atherosclerosis through anti-inflammation while CTRP5 and CTRP9 may be more involved in the metabolic process than inflammatory response.